Sandler Capital Management’s Exact Sciences EXAS Stock Holding History

Sandler Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-90,000	Closed	-$11.9M	–	109
2020 Q4	$11.9M	Buy	+90,000	New	+$10.9M	1.39%	27
2018 Q3	–	Sell	-150,000	Closed	-$8.97M	–	127
2018 Q2	$8.97M	Buy	+150,000	New	+$8.07M	0.75%	50
2014 Q4	–	Sell	-458,200	Closed	-$8.88M	–	214
2014 Q3	$8.88M	Buy	+458,200	New	+$8.4M	0.42%	101

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Sandler Capital Management's EXAS Position: Q2 2023 in Review

Sandler Capital Management sold out of Exact Sciences (EXAS) in Q2 2023, closing a stake of 67,181 shares — an estimated $4.56M sold.

Sandler Capital Management first reported a position in EXAS in Q2 2015 and held it in 3 quarters. The position peaked at $4.56M in Q1 2023. 654 funds tracked by Wall St. Rank hold EXAS as of Q2 2023.

Sandler Capital Management reported no remaining Exact Sciences position as of Q2 2023 after selling out during the quarter.
Sandler Capital Management sold 67,181 Exact Sciences shares in Q2 2023, an estimated $4.56M.
Sandler Capital Management first reported a position in Exact Sciences in Q2 2015 and held it in 3 quarters.
Sandler Capital Management's Exact Sciences position peaked at $4.56M in Q1 2023.
654 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2023.

Based on Sandler Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.